series-c-plus
Stage
2016
Founded
1
Investors
About
Elucid Bioimaging is a medical technology company leveraging machine intelligence to improve the accuracy, experience, and cost-effectiveness of vascular diagnostic imaging. Its flagship product, PlaqueIQ, is the first FDA-cleared and CE-marked, histology-validated, non-invasive image analysis software for evaluating coronary CT angiograms to provide multi-dimensional visualization, structural measurements, and plaque composition to inform risk of heart attack or stroke and personalized treatmen
Explore Elucid Bioimaging's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.